Karyopharm - oncology

[anonymous]

Sree if you’re not happy just leave already instead of complaining to everyone. Aren’t you in charge of deals? Look in mirror lady or go back to Nofartis

 

[anonymous]

Stock dropped to 1.69. Down, down, down

 

[anonymous]

Shares dropped to 1.64 today.

 

[anonymous]

It’s bad… The Street knows something. Dropping on low volume…sellers are trying to dump and buyers aren’t buying at $1.50.

 

[anonymous]

It’s bad… The Street knows something. Dropping on low volume…sellers are trying to dump and buyers aren’t buying at $1.50.

Down to 1.48. It’s bloody.

 

[anonymous]

Dick doesn’t know dick.

 

[anonymous]

It’s bad… The Street knows something. Dropping on low volume…sellers are trying to dump and buyers aren’t buying at $1.50.

Why wouldn’t it be going to hell? Look at the mental giants you have calling the shots RP, LD... It’d actually be amazing if it wasn’t a dumpster fire

 

[anonymous]

Yeah you’re right the mental giants running the company are the CFO, CEO and Commercial Head. CFO responsible for stock. How could it can any better with Mike at helm?

 

[anonymous]

Institutional owners may consider drastic measures as Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) recent US$31m drop adds to long-term losses - Simply Wall St News

Institutional owners may consider drastic measures as Karyopharm Therapeutics Inc.'s (NASDAQ:KPTI) recent US$31m drop adds to long-term losses

 

[anonymous]

Yeah you’re right the mental giants running the company are the CFO, CEO and Commercial Head. CFO responsible for stock. How could it can any better with Mike at helm?

Dick doesn’t know dick.

 

[anonymous]

Paulson is lazy

 

[anonymous]

Biogen takes nuclear option, terminating Karyopharm ALS pact after getting a look at phase 1 data

Biogen takes nuclear option, terminating Karyopharm ALS pact after getting a look at phase 1 data

 

[anonymous]

Biogen takes nuclear option, terminating Karyopharm ALS pact after getting a look at phase 1 data

Biogen takes nuclear option, terminating Karyopharm ALS pact after getting a look at phase 1 data

Yeah, that was a year ago dummy.

 

[anonymous]

Karyopharm Stock: Unlikely To Ever Be Profitable (NASDAQ:KPTI) | Seeking Alpha

Selinexor's Toxicity Makes It Unlikely For Karyopharm To Ever Be Profitable

https://seekingalpha.com/article/45...unlikely-for-karyopharm-to-ever-be-profitable

Despite gaining approval for the treatment of MM and DLBCL, Karyopharm is still unprofitable as the toxic effects of selinexor make it difficult for the drug to gain enough usage to generate significant revenue for the company.

Karyopharm's net losses have exceeded $100 million in the past two years, and their high R&D expenses are expected to persist as they aim to expand selinexor's indications. Due to these factors, the company is expected to continue posting substantial net losses, making it an unappealing investment option.

 

[anonymous]

Stock down to 1.46 today. New low.

 

[anonymous]

Stock down to 1.46 today. New low.

And they keep telling us it’s call going to be fine. What a crock!

 

[You know who]

And they keep telling us it’s call going to be fine. What a crock!

It’s all going to be fine.

Now, get back to pretending to work.

 

[anonymous]

Down to 1.48. It’s bloody.

Everyone look for change in their ash tray to buy stock

 

[anonymous]

And they keep telling us it’s call going to be fine. What a crock!

Dick is a dick

 

[anonymous]

It IS nicknamed Krazyopharm!